FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * White Winston Select Asset Fund Series Fund MP-18, LLC 2. Issuer Name and Ticker or Trading Symbol MusclePharm Corp [ MSLP ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)
265 FRANKLIN ST., SUITE 1702, 
3. Date of Earliest Transaction (MM/DD/YYYY)
3/29/2022
(Street)
BOSTON, MA 02110
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  3/29/2022    S(1)    626826  D $0.00 (2) 3021529  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  On March 29, 2022 (the "Transaction Date"), the Reporting Persons transferred 626,826 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), in an off-market transaction (the "Transaction").
(2)  For purposes of the Transaction, the value of the transferred shares of Common Stock was deemed to be $0.39 per share, the last reported sale price of the Issuer's Common Stock on the Transaction Date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
White Winston Select Asset Fund Series Fund MP-18, LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110

X

White Winston Select Asset Funds, LLC
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110

X

Enright Todd M.
C/O WHITE WINSTON SELECT ASSET FUNDS, LL
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110

X

BLUNDELL MARK
C/O WHITE WINSTON SELECT ASSET FUNDS, LL
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110

X

Feagan Donald
C/O WHITE WINSTON SELECT ASSET FUNDS, LL
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110

X

Mahoney Robert P
C/O WHITE WINSTON SELECT ASSET FUNDS, LL
265 FRANKLIN ST., SUITE 1702
BOSTON, MA 02110

X


Signatures
White Winston Select Asset Fund Series Fund MP-18, By: White Winston Select Asset Funds, LLC, its Manager, By: /s/ Todd M. Enright, Manager 3/31/2022
**Signature of Reporting Person Date
White Winston Select Asset Funds, LLC, By: /s/ Todd M. Enright, Manager 3/31/2022
**Signature of Reporting Person Date
/s/ Todd M. Enright 3/31/2022
**Signature of Reporting Person Date
/s/ Mark Blundell 3/31/2022
**Signature of Reporting Person Date
/s/ Donald Feagan 3/31/2022
**Signature of Reporting Person Date
/s/ Robert P. Mahoney 3/31/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Muscle Pharm (PK) (USOTC:MSLP)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Muscle Pharm (PK) Charts.
Muscle Pharm (PK) (USOTC:MSLP)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Muscle Pharm (PK) Charts.